Wednesday, 8 April 2020

Fujifilm to start phase II clinical trial of Avigan for COVID-19 patients in U.S.

Fujifilm Holdings Corp said it will start phase II clinical trials of its anti-flu drug Avigan for COVID-19 patients in the United States.


No comments:

Post a Comment